Arama Sonuçları - Rayne H. Rouce

Sonuçları Daraltın
  1. 1
    The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

    The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer Yazar: Katayoun Rezvani, Rayne H. Rouce

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Cell and gene therapy accessibility

    Cell and gene therapy accessibility Yazar: Rayne H. Rouce, Matthew H. Porteus

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Editorial
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Epstein–Barr virus lymphoproliferative disease after hematopoietic stem cell transplant

    Epstein–Barr virus lymphoproliferative disease after hematopoietic stem cell transplant Yazar: Rayne H. Rouce, Chrystal U. Louis, Helen E. Heslop

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies

    A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies Yazar: Maksim Mamonkin, Rayne H. Rouce, Haruko Tashiro, Malcolm K. Brenner

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Engineering Natural Killer Cells for Cancer Immunotherapy

    Engineering Natural Killer Cells for Cancer Immunotherapy Yazar: Katayoun Rezvani, Rayne H. Rouce, Enli Liu, Elizabeth J. Shpall

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions

    Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions Yazar: Jeremy Allen, Diane Berry, Francesca Cook, Ashley Hume, Rayne H. Rouce, Anirudh Srirangam, Jennifer Wellman, Caitlin K McCombs

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy

    Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy Yazar: Gerrit Weber, Ignazio Caruana, Rayne H. Rouce, A. John Barrett, Ulrike Gerdemann, Ann M. Leen, Karen R. Rabin, Catherine M. Bollard

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies

    CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies Yazar: Diogo Gomes‐Silva, Madhuwanti Srinivasan, Sandhya Sharma, Ciaran M. Lee, Dimitrios L. Wagner, Timothy Davis, Rayne H. Rouce, Gang Bao, Malcolm K. Brenner, Maksim Mamonkin

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1

    Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1 Yazar: Haruko Tashiro, Tim Sauer, Thomas Shum, Kathan Parikh, Maksim Mamonkin, Bilal Omer, Rayne H. Rouce, Premal Lulla, Cliona M. Rooney, Stephen Gottschalk, Malcolm K. Brenner

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Risk of T-cell Malignancy Following CAR T cells in Children, Adolescents and Young Adults

    Risk of T-cell Malignancy Following CAR T cells in Children, Adolescents and Young Adults Yazar: Adam J. Lamble, Liora M. Schultz, Khanh Nguyen, Emily M. Hsieh, Kevin O. McNerney, Rayne H. Rouce, Rebecca Gardner, Sara Ghorashian, Nirali N. Shah, Shannon L. Maude

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia

    CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia Yazar: Diogo Gomes‐Silva, Erden Atilla, Pınar Ataca Atilla, Feiyan Mo, Haruko Tashiro, Madhuwanti Srinivasan, Premal Lulla, Rayne H. Rouce, Joaquim M. S. Cabral, Carlos A. Ramos, Malcolm K. Brenner, Maksim Mamonkin

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies

    Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies Yazar: LaQuisa C. Hill, Rayne H. Rouce, Tyler S. Smith, Lina Yang, Madhuwanti Srinivasan, Huimin Zhang, Silvana Perconti, Birju Mehta, Olga Dakhova, Josalind Randall, Bambi Grilley, Helen E. Heslop, Malcolm K. Brenner, Maksim Mamonkin

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia

    The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia Yazar: Rayne H. Rouce, Hila Shaim, Takuya Sekine, Gerrit Weber, Brandon Ballard, Sae-Kwang Ku, Cecilia Barese, V. Murali, M-F Wu, Honghui Liu, Elizabeth J. Shpall, Catherine M. Bollard, Karen R. Rabin, Katy Rezvani

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

    EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation Yazar: Lauren P. McLaughlin, Rayne H. Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng‐Fen Wu, Fahmida Hoq, Bambi Grilley, Andrea M. Marcogliese, Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia Yazar: Alan S. Wayne, Van Huynh, Nobuko Hijiya, Rayne H. Rouce, Patrick A. Brown, Joerg Krueger, Carrie L. Kitko, Edward Ziga, Michelle L. Hermiston, Michael K. Richards, André Baruchel, Petra Schuberth, John M. Rossi, Lang Zhou, Lovely Goyal, Rajul K. Jain, Remus Vezan, Behzad Kharabi Masouleh, Daniel W. Lee

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

    In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas Yazar: Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson, A. Reyna, Neeharika Narala, Gayatri Vyas, Birju Mehta, Huimin Zhang, Olga Dakhova, George Carrum, Rammurti T. Kamble, Adrian P. Gee, Zhuyong Mei, Meng-Fen Wu, Hao Liu, Bambi Grilley, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Barbara Savoldo, Gianpietro Dotti

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

    T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects Yazar: Spyridoula Vasileiou, Premal Lulla, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Wendy L. Callejas, Mrinalini Bilgi, Tao Wang, Meng‐Fen Wu, Rammurti T. Kamble, Carlos A. Ramos, Rayne H. Rouce, Zihua Zeng, Adrian P. Gee, Bambi Grilley, Juan F. Vera, Catherine M. Bollard, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Ann M. Leen, George Carrum

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

    Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD Yazar: Ahmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, Claude Chew, Takuya Sekine, Nichola Cooper, Stephan Mielke, Hugues de Lavallade, Muharrem Müftüoǧlu, Irina Fernandez Curbelo, Enli Liu, Paolo A. Muraro, Amin M. Alousi, Kate Stringaris, Simrit Parmar, Nina Shah, Hila Shaim, Eric Yvon, Jeffrey J. Molldrem, Rayne H. Rouce, Richard Champlin, Ian McNiece, Claudia Mauri, Elizabeth J. Shpall, Katayoun Rezvani

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

    Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs Yazar: David Steffin, Ibrahim N. Muhsen, LaQuisa C. Hill, Carlos A. Ramos, Nabil Ahmed, Meenakshi Hegde, Tao Wang, Meng-Fen Wu, Stephen Gottschalk, Sarah Burkhead Whittle, Premal Lulla, Maksim Mamonkin, Bilal Omer, Rayne H. Rouce, Andras Heczey, Leonid S. Metelitsa, Bambi Grilley, Catherine Robertson, Virginia Torrano, Natalia Lapteva, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

    T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells Yazar: Natalia Lapteva, Margaret Gilbert, Iulia Diaconu, Lisa Rollins, Mina Al-Sabbagh, Swati Naik, Robert A. Krance, Tamara Tripic, Manasa Hiregange, Darshana Raghavan, Olga Dakhova, Rayne H. Rouce, Hao Liu, Bilal Omer, Barbara Savoldo, Gianpietro Dotti, Conrad Russel Cruz, Keli Sharpe, Melissa Gates, Aaron Orozco, April Durett, Elizabeth Pacheco, Adrian P. Gee, Carlos A. Ramos, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: